+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Branched Thoracic Stent Grafts Market by Device Type, Graft Material, Application, End-User, Patient Age Group, Delivery Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084643
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pioneering Minimally Invasive Solutions for Complex Aortic Pathologies

Branched thoracic stent grafts have emerged as a critical innovation for managing complex thoracic aortic pathologies. These devices provide a minimally invasive alternative to open surgery for patients with aneurysms and dissections that involve branch vessels. By integrating branch extensions into a single implant, they allow targeted perfusion of major arteries while excluding diseased aortic segments. This dual capability addresses the need to preserve vital circulation to the brain, spinal cord, and visceral organs, significantly expanding the applicability of endovascular repair.

The recent wave of technological improvements, including lower-profile delivery systems, enhanced graft materials, and more precise imaging guidance, has accelerated adoption in high-volume vascular centers. Interventional teams now tackle challenging anatomies that were once deemed inoperable. As a result, clinical outcomes have improved, with reduced perioperative morbidity and shorter hospital stays compared to traditional open repair. These advances underscore the pivotal role of branched thoracic stent grafts in the evolution of endovascular therapy and highlight the importance of understanding market dynamics for industry stakeholders, payers, and health systems alike.

Evolution of Approval Pathways and Clinical Practices Driving Adoption

Regulatory bodies and clinical practice guidelines have evolved in tandem with device innovation to facilitate broader access to branched thoracic stent grafts. Approval pathways have been streamlined through real-world evidence studies and registries, enabling iterative enhancements and accelerated market introductions. The convergence of sophisticated imaging modalities and advanced planning software has transformed preoperative assessment, reducing procedural time and enhancing precision.

On the reimbursement front, shifts toward value-based care models have prompted payers to recognize the long-term cost benefits of less invasive approaches. Bundled payment initiatives and outcome-based contracts incentivize providers to adopt technologies that minimize complications and readmissions. Meanwhile, training programs for vascular surgeons and interventional cardiologists now emphasize endovascular techniques, embedding branched graft expertise into the next generation of practitioners.

Concurrently, partnerships between device manufacturers and academic centers have fostered innovation hubs, ensuring that iterative design improvements align with real-world clinical needs. As a result, the landscape is characterized by rapid evolution, where technological, regulatory, and educational shifts collectively advance patient care and market growth.

Navigating Rising Trade Barriers and Supply Chain Adaptations

The introduction of new tariffs on key medical device imports in 2025 has introduced additional cost pressures across the branched thoracic stent graft supply chain. Components sourced from overseas suppliers now face increased duties, affecting both prime materials and specialized delivery systems. These additional levies have prompted manufacturers to reassess sourcing strategies, invest in domestic production capabilities, and explore tariff mitigation mechanisms such as bonded warehouse programs.

Manufacturers have begun to localize critical production stages, including graft weaving and branch connector assembly, to reduce exposure to tariff fluctuations. Concurrently, procurement teams are renegotiating supplier contracts and aggregating demand across product portfolios to secure more favorable terms. In markets where reimbursement fails to keep pace with device cost increases, some providers have initiated cost-sharing discussions with payers to maintain procedure accessibility. These collective responses reflect a strategic pivot to maintain supply chain resilience and protect patient access despite evolving trade policies.

Decoding Market Segments by Configuration, Material, Application, and User

Analysis across device configurations reveals that grafts with four integrated branch extensions are gaining traction in anatomies requiring complex revascularization, while two-branch designs remain the workhorse for more straightforward pathologies. Material selection plays a pivotal role, with polyethylene terephthalate fibers dominating current offerings and expanded polytetrafluoroethylene emerging as a viable alternative for enhanced biocompatibility. When segmenting by clinical application, repairs of thoracic aneurysms account for a substantial share, yet the growing use of branched grafts in thoracoabdominal aneurysms and acute dissections-particularly type B-signals expanding procedural breadth.

The setting of care also shapes adoption patterns. High-volume surgical suites within public and private hospitals retain leadership in procedure volumes, yet hospital-owned and independent ambulatory centers are increasingly offering these repairs to capitalize on efficiency gains. Specialty clinics focused on vascular interventions are likewise integrating branched grafts into their service mix. Demographic insights illustrate that patients over 65 represent the largest cohort, driven by higher prevalence of degenerative aortic disease, although a notable uptick in interventions among younger adults underscores early detection initiatives. Lastly, endovascular-only delivery remains predominant, but hybrid approaches combining open surgical access with endovascular components are carving out a niche for complex cases.

Regional Drivers and Country-Level Adoption Dynamics

In the Americas, a robust reimbursement environment and extensive clinical infrastructure have cemented leadership in branched graft adoption. The presence of key regulatory approvals enables swift market entry for new device iterations. Growth in Canada and Latin America, though currently more modest, is underpinned by expanding academic collaborations and the gradual build-out of endovascular suites.

Europe, the Middle East and Africa illustrate a heterogeneous landscape. Western European nations maintain stable adoption driven by mature health systems and centralized purchasing models, while Eastern European markets display accelerating uptake in specialized vascular centers. In the Middle East, government-funded healthcare initiatives are driving procurement of advanced graft systems. Across Africa, niche programs in tertiary hospitals set the stage for future penetration as investment in interventional cardiology grows.

Asia-Pacific exhibits some of the fastest expansion rates, fueled by rising procedural volumes in Japan, Australia, and emerging markets such as China and India. Local manufacturing partnerships and government incentives to bolster domestic medtech industries have reduced cost barriers. Training initiatives sponsored by device manufacturers further support clinician proficiency, reinforcing the region’s critical role in global growth trajectories.

Competitive Strategies Shaping the Future of Graft Innovation

A handful of global corporations and innovative specialized firms are shaping the branched thoracic stent graft landscape. Market leaders have focused on expanding their product portfolios with modular branch options and next-generation delivery systems that feature lower-profile sheaths and enhanced navigability. Strategic alliances between established players and nimble start-ups have accelerated the translation of novel scaffold architectures and bioactive coatings into clinical use.

Emerging entrants are differentiating through investment in automated planning software, leveraging artificial intelligence to streamline branch alignment within complex arch anatomies. Several companies are pursuing development of graft materials with improved fatigue resistance and reduced thrombogenicity, aiming to extend long-term patency. Partnerships with academic research centers and participation in multicenter clinical registries further bolster credibility and support evidence generation. This competitive interplay fosters continuous improvement and drives rapid iteration across the market, ensuring that technological leadership remains a central battleground.

Aligning Innovation, Supply Chain, and Value-Based Partnerships

Industry leaders must sharpen their focus on modular product architectures that accommodate varied anatomical demands while minimizing inventory burden. Investments in integrated digital planning tools will be essential to differentiate offerings and enhance clinical workflows. Engaging in outcome-based contracting with healthcare systems can reinforce value propositions, particularly as payers prioritize cost-effective solutions with demonstrable patient benefits.

Building resilient supply chains through regional manufacturing partnerships will mitigate tariff impacts and safeguard against geopolitical disruptions. Companies should also explore tiered product strategies to address emerging markets with tailored pricing models. Training and education programs, co-developed with leading vascular centers, will accelerate adoption by ensuring procedural proficiency. Moreover, collaborations with data analytics providers can unlock real-world insights, facilitating continuous product refinement and regulatory support. By aligning innovation, commercialization, and evidence generation, organizations can captivate provider interest and secure sustainable growth.

Integrative Framework of Data Sources and Analytical Processes

This analysis synthesizes data from proprietary interviews with leading vascular surgeons, interventional cardiologists, and procurement specialists, complemented by insights from clinical registries and peer-reviewed literature. Market dynamics were further vetted through engagement with regulatory experts and reimbursement analysts to ensure comprehensive understanding of approval pathways and tariff implications. Device specifications and procedural volumes were cross-referenced with health system databases to validate adoption patterns across regions.

Segmentation analyses were conducted by mapping device configurations, graft materials, clinical applications, care settings, patient demographics, and delivery modes against real-world procedure data. Regional insights draw upon national health expenditures, policy frameworks, and medtech investment trends. Competitive landscape mapping incorporated patent filings, alliance announcements, and product launch timelines. Qualitative findings from expert forums were triangulated with quantitative data to deliver a nuanced perspective on market evolution, ensuring that conclusions and recommendations rest on a rigorous, multi-source foundation.

Synthesis of Market Forces and Strategic Imperatives

The branched thoracic stent graft market stands at an inflection point, propelled by converging forces of technological sophistication, evolving regulatory support, and shifting reimbursement paradigms. As devices become more versatile and accessible, adoption will continue to spread beyond high-volume centers into broader clinical practice. Trade policy headwinds necessitate agile responses in sourcing and manufacturing, underscoring the importance of strategic supply chain investments.

Segmentation and regional analyses reveal that patient-centric innovations and localized manufacturing strategies will determine which players rise to the forefront. Competitive differentiation through digital planning solutions and material breakthroughs will define long-term market leadership. By embracing value-based partnerships and outcome-focused contracts, industry participants can solidify their positions in a market that increasingly rewards demonstrable clinical and economic benefits.

Ultimately, stakeholders who integrate data-driven insights with proactive investment in technology and infrastructure will shape the future of endovascular therapy. This holistic approach will ensure that branched thoracic stent grafts fulfill their promise of safer, more effective treatment options for patients worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Four Branched
    • Three Branched
    • Two Branched
  • Graft Material
    • Dacron
    • Eptfe
  • Application
    • Aortic Aneurysm
      • Thoracic Aneurysm
      • Thoracoabdominal Aneurysm
    • Aortic Dissection
      • Type A
      • Type B
  • End-User
    • Ambulatory Surgery Centers
      • Hospital Owned
      • Independent
    • Hospitals
      • Private
      • Public
    • Specialty Clinics
  • Patient Age Group
    • 18-45
    • 46-65
    • 65+
  • Delivery Mode
    • Endovascular
    • Hybrid
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • Cook Medical LLC
  • Bolton Medical, Inc.
  • Jotec GmbH
  • MicroPort Scientific Corporation
  • Endospan Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Branched Thoracic Stent Grafts Market, by Device Type
8.1. Introduction
8.2. Four Branched
8.3. Three Branched
8.4. Two Branched
9. Branched Thoracic Stent Grafts Market, by Graft Material
9.1. Introduction
9.2. Dacron
9.3. Eptfe
10. Branched Thoracic Stent Grafts Market, by Application
10.1. Introduction
10.2. Aortic Aneurysm
10.2.1. Thoracic Aneurysm
10.2.2. Thoracoabdominal Aneurysm
10.3. Aortic Dissection
10.3.1. Type A
10.3.2. Type B
11. Branched Thoracic Stent Grafts Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.2.1. Hospital Owned
11.2.2. Independent
11.3. Hospitals
11.3.1. Private
11.3.2. Public
11.4. Specialty Clinics
12. Branched Thoracic Stent Grafts Market, by Patient Age Group
12.1. Introduction
12.2. 18-45
12.3. 46-65
12.4. 65+
13. Branched Thoracic Stent Grafts Market, by Delivery Mode
13.1. Introduction
13.2. Endovascular
13.3. Hybrid
14. Americas Branched Thoracic Stent Grafts Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Branched Thoracic Stent Grafts Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Branched Thoracic Stent Grafts Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. W. L. Gore & Associates, Inc.
17.3.3. Terumo Corporation
17.3.4. Cook Medical LLC
17.3.5. Bolton Medical, Inc.
17.3.6. Jotec GmbH
17.3.7. MicroPort Scientific Corporation
17.3.8. Endospan Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BRANCHED THORACIC STENT GRAFTS MARKET MULTI-CURRENCY
FIGURE 2. BRANCHED THORACIC STENT GRAFTS MARKET MULTI-LANGUAGE
FIGURE 3. BRANCHED THORACIC STENT GRAFTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BRANCHED THORACIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BRANCHED THORACIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRANCHED THORACIC STENT GRAFTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY FOUR BRANCHED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THREE BRANCHED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TWO BRANCHED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DACRON, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY EPTFE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY 18-45, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY 46-65, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY 65+, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 63. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 65. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 66. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 68. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. CANADA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 124. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 126. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 134. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 136. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 137. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 139. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. FRANCE BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 152. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 153. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 154. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 156. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 157. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 159. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. ITALY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 163. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 166. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. SPAIN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 202. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 203. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 204. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 206. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 207. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. DENMARK BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 222. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 223. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 224. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 226. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 227. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 229. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. QATAR BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 232. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 233. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 234. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 236. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 237. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 239. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 241. FINLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 262. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 263. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 264. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 266. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 267. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 269. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 271. EGYPT BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 272. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 273. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 274. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 276. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 277. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 279. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 280. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 281. TURKEY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 292. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 293. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 294. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 296. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC DISSECTION, 2018-2030 (USD MILLION)
TABLE 297. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 299. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 300. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. NORWAY BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 302. POLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 303. POLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 304. POLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. POLAND BRANCHED THORACIC STENT GRAFTS MARKET SIZE, BY AORTIC ANEURYSM, 2018-2030 (USD MILLION)
TABLE 306. POL

Companies Mentioned

The companies profiled in this Branched Thoracic Stent Grafts market report include:
  • Medtronic plc
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • Cook Medical LLC
  • Bolton Medical, Inc.
  • Jotec GmbH
  • MicroPort Scientific Corporation
  • Endospan Ltd.

Methodology

Loading
LOADING...